Browse Cat (Felis catus) antibodies and recombinant proteins — species-validated reagents for veterinary medicine, comparative oncology, and infectious disease research. The domestic cat genome (~2.35 Gb, 21,865 protein-coding genes) shares extensive conserved synteny with the human genome, and over 250 naturally occurring hereditary diseases analogous to human disorders have been documented in cats, including hypertrophic cardiomyopathy (HCM), polycystic kidney disease (PKD), lysosomal storage disorders, and spinal muscular atrophy. Feline infectious agents — including feline immunodeficiency virus (FIV, a natural lentiviral model of HIV/AIDS), feline leukemia virus (FeLV), and feline coronavirus (FCoV/FIPV) — provide powerful spontaneous disease models for antiviral and vaccine development. Our reagents support research across veterinary diagnostics and clinical pathology, comparative genomics and breed-specific genetic disorders, feline retroviral and coronavirus biology, immune marker profiling (CD antigens, cytokines, immunoglobulins), and companion animal oncology. RUO
Every antibody is validated in its listed applications (WB, IHC, IF, ELISA, FC) with supporting images and data on the product page. We use positive and negative controls plus knockout/knockdown verification where available.
Yes — HRP, AP, biotin, FITC, PE, APC, Alexa Fluor, and other fluorochrome conjugates are available. Custom conjugation services are also offered for bulk orders.
Most antibodies target human, mouse, and rat. Many show validated cross-reactivity with additional species including cat. Check the product datasheet for confirmed reactivity data.
If a product does not perform as described under recommended conditions, contact us within 30 days for replacement or credit. Our technical team will help troubleshoot first.
Yes — our parent company AtaGenix offers full custom antibody development from immunogen design through hybridoma screening and scale-up production.
All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.
1. Montague MJ, Li G, Gandolfi B, et al. Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication. Proc Natl Acad Sci USA. 2014;111(48):17230-17235. DOI
2. Pontius JU, Mullikin JC, Smith DR, et al. Initial sequence and comparative analysis of the cat genome. Genome Res. 2007;17(11):1675-1689. DOI
3. O’Brien SJ, Johnson W, Driscoll C, et al. State of cat genomics. Trends Genet. 2008;24(6):268-279. DOI
4. Lyons LA. DNA mutations of the cat: the good, the bad and the ugly. J Feline Med Surg. 2015;17(3):203-219. DOI
Feline
ELISA, WB
Human
IgE
SAA2222
Feline
ELISA, WB
Human
IgE
SAA2223
Feline
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG4
REGN1909
E. coli
P30440
Val18-Arg109
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Felis catus (Cat) (Felis silvestris catus)
Feline
ELISA, IHC, WB
Rabbit
IgG
Feline
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG4
REGN1908
Mammalian cells
XP_023100999.2 & Q5MGS7
Ala23-Ser296
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Felis catus (Cat) (Felis silvestris catus)
Mammalian cells
A0A2I2UKP7
Ser24-Gln159
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Felis catus (Cat) (Felis silvestris catus)
Mammalian cells
XP_044890973.1
Met29-Ser190
SDS-PAGE, WB, ELISA, Immunogen, Bioactivity testing in progress
Felis catus (Cat) (Felis silvestris catus)
E. coli
NP_001138982.1
Leu25-Leu169
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Felis catus (Cat) (Felis silvestris catus)